Figure 5 | Scientific Reports

Figure 5

From: Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival

Figure 5

Clinical correlation of cluster formation in (a) lung cancer patient developing hyper progression (by PET/CT scan) on nivolumab treatment for 4 cycles (b) breast cancer patient with no sign of cancer progression (by PET scan) before and after treatment for 2 cycles (c) breast cancer patient with progressive cancer (by CT scan) before and after treatment for 4 cycles.

Back to article page